Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/19/2012 | CN101641091B Tamibarotene capsule preparation |
09/19/2012 | CN101554461B Medicine for treating psoriasis and preparation method of capsule thereof |
09/19/2012 | CN101537037B Amaranth berberine tablet and preparation method thereof |
09/19/2012 | CN101480397B Cefixime orally disintegrating tablet and preparation method thereof |
09/19/2012 | CN101472573B Reduced coenzyme Q10-containing composition and method for producing the same |
09/19/2012 | CN101322739B Prescription of Chinese medicine health care capsules mixed with nucleotide and aminoacid and preparing technique |
09/19/2012 | CN101297968B Preparation of pig serum immunoglobulin microsphere novel dosage form |
09/19/2012 | CN101219115B Sustained drug-release particles and process for producing the same |
09/19/2012 | CN101027077B Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid |
09/18/2012 | US8269040 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease |
09/18/2012 | US8268892 Isomers of 2-(diphenylmethylsulfinyl)acetamide; therapy for attention deficit disorders; solid dosage form |
09/18/2012 | US8268804 Minocycline oral dosage forms for the treatment of acne |
09/18/2012 | US8268790 Dermatalogical formulations |
09/18/2012 | US8268367 Topical herbal formulation for treatment of acne and skin disorders |
09/18/2012 | US8268359 Organic polymer-inorganic fine particle antimicrobial composites and uses thereof |
09/18/2012 | US8268358 Use of simple amino acids to form porous particles |
09/18/2012 | US8268357 Processes for the preparation of lipophilic drug delivery vehicles |
09/18/2012 | US8268356 Aqueous film coating solution, film coated granule and tablet using the same |
09/18/2012 | US8268355 Silica particle comprising an organolanthanide compound, preparation process therefor and uses thereof |
09/18/2012 | US8268354 Sonic low pressure spray drying |
09/18/2012 | US8268353 Polymer latex compound |
09/18/2012 | US8268352 Modified release composition for highly soluble drugs |
09/18/2012 | US8268351 time-release agents comprising water-swellable matrix cores containing estrogen derivative extracted from animals surrounded by film-forming coatings |
09/18/2012 | US8268350 Binders for tablets with high strength based on finely divided vinyllactam polymers, the production and use thereof |
09/18/2012 | US8268349 Solid pharmaceutical dosage form |
09/18/2012 | US8268348 Combinations and modes of administration of therapeutic agents and combination therapy |
09/18/2012 | US8268347 Dual action, inhaled formulations providing both an immediate and sustained release profile |
09/18/2012 | US8268345 Multipurpose hydrogel compositions and products |
09/18/2012 | US8268344 Particle-containing complex porous materials |
09/18/2012 | US8268343 Non-hormonal vaginal contraceptive |
09/18/2012 | US8268342 Biodegradable polymer scaffold and process for preparation thereof |
09/18/2012 | US8268341 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
09/18/2012 | US8268337 Nontoxic killer of E. coli and other problem microorganisms |
09/18/2012 | US8268334 Aqueous acidic hard surface cleaning and disinfecting compositions |
09/18/2012 | US8268333 Orally administered agent and an orally administered agent/supporting substrate complex |
09/18/2012 | US8268332 Method for dermatological treatment using chromophores |
09/18/2012 | US8268323 Conformationally stabilized HIV envelope immunogens |
09/18/2012 | US8268292 Obovatol having anti-anxiety activity |
09/18/2012 | US8268240 Ciclesonide-containing sterile aqueous suspension |
09/18/2012 | US8267921 Manually operable portable infusion device |
09/18/2012 | US8267920 Methods and systems for neural maintenance and regeneration |
09/18/2012 | US8267915 Dual well port device |
09/18/2012 | US8267907 Device and method for exothermic treatment of eyelid diseases |
09/18/2012 | US8267906 Transdermal delivery apparatus and method |
09/18/2012 | US8267905 Apparatus and method for delivery of therapeutic and other types of agents |
09/18/2012 | CA2561109C Gastric retention system |
09/18/2012 | CA2549516C Percutaneous absorption-type pharmaceutical preparation |
09/18/2012 | CA2532487C Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances, and a method for producing said pharmaceutical dosage form |
09/18/2012 | CA2531832C Powdery formulations for inhalation, containing a novel anticholinergic agent |
09/18/2012 | CA2517120C Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
09/18/2012 | CA2515259C Use of acetylsalicylic acid for the treatment of hemorrhoidal disease |
09/18/2012 | CA2511185C A physically and chemically stable nicotine-containing particulate material |
09/18/2012 | CA2507002C Solid drug for oral use |
09/18/2012 | CA2493604C Patch containing fentanyl for mucous membrane of oral cavity |
09/18/2012 | CA2493165C Oral composition with enhanced organoleptic properties comprising an enzyme and cyclodextrin |
09/18/2012 | CA2492156C Tablet composition containing kampo medicinal extract and its manufacturing process |
09/18/2012 | CA2480226C Stable pharmaceutical composition containing factor viii |
09/18/2012 | CA2477288C Biodegradable polymeric material for biomedical applications |
09/18/2012 | CA2470463C Tooth whitening products and methods of making the same |
09/18/2012 | CA2461896C Injections for eye tissues containing drug bonded to polyethylene glycol |
09/18/2012 | CA2388733C Food supplement for increasing lean mass and strength |
09/18/2012 | CA2378943C Super-active porcine growth hormone releasing hormone analog |
09/18/2012 | CA2226013C Preparations and methods for the treatment of t cell mediated diseases |
09/13/2012 | WO2012122544A2 Protein nanoparticle dispersions |
09/13/2012 | WO2012122535A2 Stable formulations for parenteral injection of peptide drugs |
09/13/2012 | WO2012122493A1 Lipid based clopidogrel compositions, methods, and uses |
09/13/2012 | WO2012122313A2 Targeted nanocarrier systems for delivery of actives across biological membranes |
09/13/2012 | WO2012122163A1 Microneedle devices and methods |
09/13/2012 | WO2012122162A1 Microneedle devices and methods |
09/13/2012 | WO2012121977A2 Dodecafluoropentane emulsion as a stroke and ischemia therapy |
09/13/2012 | WO2012121971A2 Locally released growth factors to mediate motor recovery after stroke |
09/13/2012 | WO2012121798A2 Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
09/13/2012 | WO2012121758A1 Melt-extruded solid dispersions containing an apoptosis-inducing agent |
09/13/2012 | WO2012121528A2 Magnetic nanocomposite specific for thyroid cancer and use thereof |
09/13/2012 | WO2012121523A2 Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection containing pemetrexed or its salt |
09/13/2012 | WO2012121461A1 Stable fast-dissolving film formulation for oral dosage form |
09/13/2012 | WO2012121395A1 Cholesterol-dependent cytolysin variant and use thereof in dds |
09/13/2012 | WO2012121202A1 Tablet-type composition for oral administration and method for producing same |
09/13/2012 | WO2012121095A1 Enteral nutrient |
09/13/2012 | WO2012120522A1 A taste masked chewable tablet of sildenafil |
09/13/2012 | WO2012120516A1 Soy protein-based structures and uses thereof |
09/13/2012 | WO2012120365A1 Stable pharmaceutical composition comprising ethinyl estradiol |
09/13/2012 | WO2012120338A1 Method for the preparaton of a levothyroxine solution |
09/13/2012 | WO2012120337A1 Aqueous paracetamol compositions and method of preparation |
09/13/2012 | WO2012120328A1 Formulation comprising phenylaminopyrimidine derivative as active agent |
09/13/2012 | WO2012120320A1 Herbal solid formulation and process for preparing the same |
09/13/2012 | WO2012120284A1 Use of glycopyrrolate for treating tachycardia |
09/13/2012 | WO2012120139A1 Implantable bio-resorbable polymer charged with fragile macromolecules |
09/13/2012 | WO2012120082A1 Adenosine and derivatives thereof for use in pain therapy |
09/13/2012 | WO2012120043A2 Method for forming drops of a first phase dispersed in a second phase substantially immiscible with the first phase |
09/13/2012 | WO2012120040A1 Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor |
09/13/2012 | WO2012119997A1 Pharmaceutical formulation for producing rapidly disintegrating tablets |
09/13/2012 | WO2012119980A1 Particles containing a growth factor, and uses thereof |
09/13/2012 | WO2012119907A1 Method of protecting biologically active substances against denaturation |
09/13/2012 | WO2012119781A2 Novel lipids, phospholipids, phospholipid and lipid compositions and their use |
09/13/2012 | WO2012119780A2 Novel lipids and novel phospholipids structures |
09/13/2012 | WO2012119729A1 Semisolid aqueous pharmaceutical composition containing tapentadol |
09/13/2012 | WO2012119728A1 Parenteral administration of tapentadol |
09/13/2012 | WO2012119727A1 Aqueous pharmaceutical formulation of tapentadol for oral administration |
09/13/2012 | WO2012119560A1 Preparation method for extractive of jinxuan hemorrhoid washing powder botanicals |